Joel Greenblatt acquired 37.5 Thousand Catalyst Pharmaceuticals shares worth $610 Thousand. That's 0.01% of their equity portfolio (926th largest holding). The first Catalyst Pharmaceuticals trade was made in Q3 2019. Since then Joel Greenblatt bought shares four more times and sold shares on seven occasions. The stake costed the investor $566 Thousand, netting the investor a gain of 7.8% so far.